Skip to main content
25 November 2024
Last updated:
Friday 22 November 2024
User account anon menu
Login
Register and subscribe
Search
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
Menu
Breadcrumb
Home
Research Directory
Research Directory
Why Oxford BioTherapeutics is targeting ADCs
Read more
How developers approach antibody drug conjugates
Read more
The art of tapping into academic expertise
Read more
Making sense of the ECJ's decision on stem cell patents
Read more
Partnering with Russia
Read more
Advancing a modular approach to antibody design
Read more
Antibodies show promise against influenza
Read more
US makes a significant reform to its patent law
Read more
Making the most of EU funding
Read more
Cardio3 BioSciences demonstrates how cardiac precurser cells treat heart disease
Read more
Pagination
First page
« First
Previous page
‹‹
…
Page
64
Page
65
Page
66
Page
67
Current page
68
Page
69
Page
70
Page
71
Page
72
…
Next page
››
Last page
Last »
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
